Genetic Technologies (LTS:0A4N) Cash Flow from Operations : $-4.18 Mil (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Genetic Technologies Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Jun. 2024, Genetic Technologies's Cash Receipts from Operating Activities was $1.45 Mil. Its Cash Payments was $-3.50 Mil. Its Dividends Paid was $0.00 Mil. Its Dividends Received was $0.00 Mil. Its Interest Paid was $0.00 Mil. Its Interest Received was $0.00 Mil. Its Taxes Refund Paid was $0.00 Mil. And its Cash Flow from Others was $-0.01 Mil. In all, Genetic Technologies's Cash Flow from Operations for the three months ended in Jun. 2024 was $-2.06 Mil.

Genetic Technologies Cash Flow from Operations Historical Data

The historical data trend for Genetic Technologies's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Cash Flow from Operations Chart

Genetic Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Cash Flow from Operations

Get a 7-Day Free Trial

-3.94

-4.81

-3.98

-6.53

-6.43

Genetic Technologies Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash Flow from Operations	Get a 7-Day Free Trial															-1.89	-0.72	-1.68	-2.06	0.28

Genetic Technologies Cash Flow from Operations Calculation

Genetic Technologies's Cash Flow from Operations for the fiscal year that ended in Jun. 2024 is calculated as:

	Cash Flow from Operations		(A: Jun. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	6.396	+	-12.823	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0	+	1.161	+	-1.161
=	-6.43

Genetic Technologies's Cash Flow from Operations for the quarter that ended in Jun. 2024 is:

	Cash Flow from Operations		(Q: Jun. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	1.447	+	-3.495	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0	+	0	+	-0.014
=	-2.06

Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.18 Mil.

Genetic Technologies (LTS:0A4N) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Genetic Technologies's cash receipts from operating activities for the three months ended in Jun. 2024 was $1.45 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Genetic Technologies's cash payments for the three months ended in Jun. 2024 was $-3.50 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.